0.3199
Catheter Precision Inc. stock is traded at $0.3199, with a volume of 40,879.
It is down -4.51% in the last 24 hours and down -21.99% over the past month.
Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023. Catheter Precision, Inc. is based in Fort Mill, South Carolina.
See More
Previous Close:
$0.335
Open:
$0.3175
24h Volume:
40,879
Relative Volume:
0.21
Market Cap:
$2.67M
Revenue:
$24,000
Net Income/Loss:
$-78.06M
P/E Ratio:
-0.011
EPS:
-28.9956
Net Cash Flow:
$-21.81M
1W Performance:
+3.19%
1M Performance:
-21.99%
6M Performance:
-27.41%
1Y Performance:
-92.78%
Catheter Precision Inc. Stock (VTAK) Company Profile
Name
Catheter Precision Inc.
Sector
Industry
Phone
973 691 2000
Address
1670 Highway 160 West, Suite 205, Fort Mill
Compare VTAK with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
VTAK
Catheter Precision Inc.
|
0.3199 | 2.67M | 24,000 | -78.06M | -21.81M | -29.00 |
![]()
ABT
Abbott Laboratories
|
130.98 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
95.12 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
346.50 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
82.60 | 108.02B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
71.53 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Catheter Precision Inc. Stock (VTAK) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-13-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
Nov-02-18 | Initiated | Maxim Group | Buy |
Catheter Precision Inc. Stock (VTAK) Latest News
Catheter Precision Reports 'Going Concern' Notice in Recent Annual Report - marketscreener.com
Catheter Precision Makes NYSE American Section 610(b) Public Announcement - The Manila Times
Catheter Precision Makes NYSE American Section 610(b) Public Announcement | VTAK Stock News - GuruFocus
Catheter Precision, Inc. Announces Receipt of Audit Opinion with Going Concern Doubt - Nasdaq
Catheter Precision Receives Critical Going Concern Warning in Latest NYSE American Disclosure - Stock Titan
Catheter Precision (VTAK) Secures US Patent for Surgical Closure Device | VTAK Stock News - GuruFocus
Catheter Precision, Inc. Receives Notice of First Patent Allowance in the US for LockeT Product Line - GlobeNewswire
Lachine Hospital Foundation Gala raises $406,500 to support the modernization of Lachine Hospital - The Manila Times
Major Patent Win: Catheter Precision's LockeT Device Gets US Protection Amid Global Expansion - Stock Titan
S&P 500 loses 5%, more than half its prior historic gain, after White House clarifies US is tariffing China at 145% - The Globe and Mail
VTAK stock touches 52-week low at $0.3 amid market challenges - Investing.com
VTAK stock touches 52-week low at $0.3 amid market challenges By Investing.com - Investing.com South Africa
Catheter Precision Inc. (VTAK) reports earnings - Quartz
Catheter Precision Q4 2024 revenue jumps 55% to USD 149K - Medical Buyer
Catheter Precision, Inc. Announces Fourth Quarter and Full Year 2024 Update and Financial Results - GlobeNewswire
Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure - The Manila Times
Catheter Precision Reports 55% Revenue Jump as LockeT Adoption Accelerates - Stock Titan
Catheter Precision to Participate in and Share Data at Upcoming Industry Conferences - The Manila Times
Breakthrough Study: Catheter Precision's LockeT Outperforms Traditional Methods in 97-Patient Trial - Stock Titan
Imperative Care Expands Precision Thrombectomy Portfolio - Diagnostic and Interventional Cardiology
Imperative Care Expands Symphony Precision Thrombectomy Portfolio with Purpose-Built Design for the Treatment of Venous Thrombosis - Business Wire
VTAK stock touches 52-week low at $0.31 amid market challenges - Investing.com Australia
VTAK stock touches 52-week low at $0.31 amid market challenges By Investing.com - Investing.com South Africa
Global 3D Cardiac Mapping System Market To Reach $2.73 Billion By 2029 With A Growth Rate Of 9.6% As Reveal... - WhaTech
3D Cardiac Mapping System Market To Reach $2.73 Billion By 2029 With A Growth Rate Of 9.6% - WhaTech
Catheter Precision to Attend and Participate in the Western Atrial Fibrillation Symposium - The Manila Times
Catheter Precision's LockeT Innovation Takes Center Stage at Elite AF Symposium - StockTitan
Ra Medical : Reports First Quarter 2019 Financial Results -May 13, 2019 at 04:07 pm EDT - Marketscreener.com
Global Magnetic Ablation Catheters Market Poised for Significant Growth, Projected to Reach USD 1,114.4 Million by 2035 Driven by Technological Advancements and Rising Cardiovascular Cases | Future Market Insights, Inc. - GlobeNewswire
Catheter Precision Inc. Engages PCG Advisory to Broaden Investor Relations Strategy - The Manila Times
ACT-ion Raises $7.5 million in Pre-Series A Round Led by BASF Venture Capital - The Manila Times
Catheter Precision Engages PCG Advisory To Broaden Investor Relations Strategy -February 10, 2025 at 08:11 am EST - Marketscreener.com
VTAK Takes Strategic Step: Partners PCG Advisory to Tap $15.1B Electrophysiology Market - StockTitan
ForexTV | Small Business Resources - ForexTV.com
Catheter Precision to Attend and Participate in the 13th Internation Symposium on Left Atrial Appendage - The Manila Times
Revolutionary LAA Closure Device LockeT Takes Center Stage at Elite Cardiac Symposium - StockTitan
Catheter Precision awards stock options to top executives - MSN
Catheter Precision closes acquisition of PeriKard - Medical Buyer
Catheter Precision awards stock options to top executives By Investing.com - Investing.com South Africa
Catheter Precision Approves Executive Stock Option Plan - TipRanks
Catheter Precision, Inc. Announces The Closing of its Acquisition of PeriKard, LLC - The Manila Times
Actelis Networks Appoints Industry Veteran Niel Ransom to Board of Directors, Enhancing Leadership in Secure Networking and Critical Infrastructure - The Manila Times
Major Cardiac Tech Acquisition: Catheter Precision Absorbs PeriKard in Strategic Market Expansion - StockTitan
Catheter Precision enters agreement to acquire PeriKard in all-stock transaction - MSN
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Masimo Taps Katie Szyman as Permanent CEO - MSN
Catheter Precision, Inc. Announces Effectiveness of 1-for-10 Reverse Stock Split - ACCESS Newswire
Catheter Precision expands share authorization and warrant exercise - MSN
Catheter Precision Inc. Stock (VTAK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cap:
|
Volume (24h):